Dr Angeles Escarti-Nebot
Dr Angeles Escarti-Nebot is Head of Non-Clinical, Principal Consultant at Scendea.
JournalNavigating early drug development investment: a detailed guide to due diligence
Funding is undoubtedly one of the major challenges small and medium-sized companies face when developing a new therapy from the bench to the clinic and eventually to the market. Suitable partnerships and potential mergers and acquisitions are key drivers to take a drug development programme to the next stage. The ...